Table 1 Subjects’ background and clinical characteristics
From: Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function
Frequency (%) | Median [Range] | |
|---|---|---|
Gender | ||
Male | 7 (35%) | |
Female | 13 (65%) | |
Age (years) | 49.5 [22–77] | |
BMI (should use weight not BMI) | 26.9 [19.6–40.6] | |
Diabetes Mellitus | 8 (40%) | |
Hypertension | 14 (70%) | |
HD access failure prior to PD initiation | 16 (80%) | |
First dialysis modality | ||
Hemodialysis | 17 (85%) | |
Peritoneal Dialysis | 3 (15%) | |
HD duration prior to PD (months) | 120 [18–240] | |
PD duration (months) | 11.5 [5–56] | |
Residual urine | 3 (15%) | |
History of peritonitis | 6 (30%) | |